Stemtech (STEK) Return on Capital Employed (2013 - 2025)
Stemtech's (STEK) quarterly Return on Capital Employed came in at 11.92% in Q4 2025, up 255.12% quarter-over-quarter from 3.36% in Q3 2025.
Stemtech (STEK) Return on Capital Employed (2013 - 2025) Analysis & Trends
Stemtech has disclosed Return on Capital Employed across 11 years of filings, most recently posting 11.92% for Q4 2025.
- Return on Capital Employed for Q4 2025 came in at 11.92%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 11.92% (changed N/A YoY), and the FY2025 annual result was 11.94%, down 387.0% from the prior year.
- Return on Capital Employed came in at 11.92% for Q4 2025 at Stemtech, up from 3.36% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 227.82% in Q2 2023 to a low of 0.05% in Q3 2023.
- The 5-year median for Return on Capital Employed is 20.42% (2024), against an average of 44.0%.
- Across the five-year window, Return on Capital Employed jumped 22061 bps in 2023 and tumbled 21523 bps in 2024, its largest moves.
- Stemtech's Return on Capital Employed stood at 44.07% in 2021, then surged by 31 bps to 57.7% in 2022, then fell by 22 bps to 44.81% in 2023, then sank by 72 bps to 12.59% in 2024, then fell by 5 bps to 11.92% in 2025.
- The last three Return on Capital Employed figures came in at 11.92% (Q4 2025), 3.36% (Q3 2025), and 9.14% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Stemtech | - | - | 354,677.00 | 11.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.92% |
| Sep 30, 2025 | 3.36% |
| Jun 30, 2025 | 9.14% |
| Mar 31, 2025 | 17.40% |
| Jun 30, 2024 | 12.59% |
| Mar 31, 2024 | 20.42% |
| Dec 31, 2023 | 44.81% |
| Sep 30, 2023 | -0.05% |
| Jun 30, 2023 | 227.82% |
| Mar 31, 2023 | 59.11% |
| Dec 31, 2022 | 57.70% |
| Sep 30, 2022 | 105.27% |
| Jun 30, 2022 | 7.21% |
| Mar 31, 2022 | 39.18% |
| Dec 31, 2021 | 44.07% |
| May 31, 2018 | 20.59% |
| Feb 28, 2018 | 26.28% |
| Nov 30, 2017 | 30.08% |
| Aug 31, 2017 | 31.28% |
| May 31, 2017 | 28.92% |